Response by Van de Werf et al to Letter Regarding Article, "STREAM-2: Half-Dose Tenecteplase or Primary Percutaneous Coronary Intervention in Older Patients With ST-Segment-Elevation Myocardial Infarction: A Randomized, Open-Label Trial"
Circulation. 2024 Feb 27;149(9):727-728.
doi: 10.1161/CIRCULATIONAHA.123.067368.
Epub 2024 Feb 26.
1 Department of Cardiovascular Sciences, KU Leuven, Belgium (F.V.d.W., P.S.).
2 The Canadian Virtual Coordinating Centre for Global Collaborative Cardiovascular Research (Canadian VIGOUR Centre), University of Alberta, Edmonton, Canada (R.C.W., P.W.A.).